Robert Besthof - Interim CEO at NRX Pharmaceuticals, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Interim CEO
Stock Symbol
NRXP, NRXPW on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Robert Besthof since 10/6/2023

Holdings reported by Robert Besthof for NRX Pharmaceuticals, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Employee Stock Option (Right to buy) 247K $49.4K $0.20 Aug 16, 2021 Direct Common Stock
Common Stock 23.7K $7.58K $0.32 Sep 15, 2021 Direct
Employee Stock Option 347K Mar 8, 2022 Direct Common Stock
Restricted Stock Units 36.3K Aug 16, 2021 Direct Common Stock

Transactions reported by Robert Besthof for NRX Pharmaceuticals, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.